These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 28089679)
1. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679 [TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy. Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma. Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769 [TBL] [Abstract][Full Text] [Related]
4. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583 [TBL] [Abstract][Full Text] [Related]
6. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Shields CL; Douglass AM; Beggache M; Say EA; Shields JA Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319 [TBL] [Abstract][Full Text] [Related]
11. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092 [TBL] [Abstract][Full Text] [Related]